BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37127832)

  • 1. Behavioral and biologic characteristics of cancer-related cognitive impairment biotypes.
    Mulholland MM; Prinsloo S; Kvale E; Dula AN; Palesh O; Kesler SR
    Brain Imaging Behav; 2023 Jun; 17(3):320-328. PubMed ID: 37127832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional connectome biotypes of chemotherapy-related cognitive impairment.
    Kesler SR; Petersen ML; Rao V; Harrison RA; Palesh O
    J Cancer Surviv; 2020 Aug; 14(4):483-493. PubMed ID: 32157609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing functional regional homogeneity (ReHo) as a B-SNIP psychosis biomarker using traditional and machine learning approaches.
    Ji L; Meda SA; Tamminga CA; Clementz BA; Keshavan MS; Sweeney JA; Gershon ES; Pearlson GD
    Schizophr Res; 2020 Jan; 215():430-438. PubMed ID: 31439419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.
    Lange M; Joly F; Vardy J; Ahles T; Dubois M; Tron L; Winocur G; De Ruiter MB; Castel H
    Ann Oncol; 2019 Dec; 30(12):1925-1940. PubMed ID: 31617564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurobiology-based Cognitive Biotypes Using Multi-scale Intrinsic Connectivity Networks in Psychotic Disorders.
    Andrés-Camazón P; Diaz-Caneja CM; Ballem R; Chen J; Calhoun VD; Iraji A
    medRxiv; 2024 May; ():. PubMed ID: 38798576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of compensatory neural hyperactivity in a subgroup of chemotherapy-treated breast cancer survivors and its association with brain aging.
    Mulholland MM; Stuifbergen A; De La Torre Schutz A; Franco Rocha OY; Blayney DW; Kesler SR
    medRxiv; 2024 Apr; ():. PubMed ID: 38712178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study.
    Paranjpe MD; Chen X; Liu M; Paranjpe I; Leal JP; Wang R; Pomper MG; Wong DF; Benzinger TLS; Zhou Y;
    Neuroimage Clin; 2019; 22():101795. PubMed ID: 30991617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer.
    Vardy JL; Stouten-Kemperman MM; Pond G; Booth CM; Rourke SB; Dhillon HM; Dodd A; Crawley A; Tannock IF
    Brain Imaging Behav; 2019 Feb; 13(1):15-26. PubMed ID: 28466438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-behavior patterns define a dimensional biotype in medication-naïve adults with attention-deficit hyperactivity disorder.
    Lin HY; Cocchi L; Zalesky A; Lv J; Perry A; Tseng WI; Kundu P; Breakspear M; Gau SS
    Psychol Med; 2018 Oct; 48(14):2399-2408. PubMed ID: 29409566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptomic Similarity Informs Neuromorphic Deviations in Depression Biotypes.
    Li J; Long Z; Sheng W; Du L; Qiu J; Chen H; Liao W
    Biol Psychiatry; 2024 Mar; 95(5):414-425. PubMed ID: 37573006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Value of Brain Structural Magnetic Resonance Imaging Combined with APOE--
    Zhao W; Yin C; Yu F; Wan L; Che S; Cui L
    Contrast Media Mol Imaging; 2022; 2022():8613024. PubMed ID: 35317127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain Structure Biomarkers in the Psychosis Biotypes: Findings From the Bipolar-Schizophrenia Network for Intermediate Phenotypes.
    Ivleva EI; Clementz BA; Dutcher AM; Arnold SJM; Jeon-Slaughter H; Aslan S; Witte B; Poudyal G; Lu H; Meda SA; Pearlson GD; Sweeney JA; Keshavan MS; Tamminga CA
    Biol Psychiatry; 2017 Jul; 82(1):26-39. PubMed ID: 27817844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine Learning of Functional Connectivity to Biotype Alcohol and Nicotine Use Disorders.
    Zhu T; Wang W; Chen Y; Kranzler HR; Li CR; Bi J
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 Mar; 9(3):326-336. PubMed ID: 37696489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain Homotopic Connectivity in Mild Cognitive Impairment APOE-ε4 Carriers.
    Shi JY; Wang P; Wang BH; Xu Y; Chen X; Li HJ
    Neuroscience; 2020 Jun; 436():74-81. PubMed ID: 32304722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural connectivity biotypes: associations with internalizing problems throughout adolescence.
    Chahal R; Weissman DG; Hallquist MN; Robins RW; Hastings PD; Guyer AE
    Psychol Med; 2021 Dec; 51(16):2835-2845. PubMed ID: 32466823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiety correlates with cortical surface area in subjective cognitive decline: APOE ε4 carriers versus APOE ε4 non-carriers.
    Sun Y; Wang X; Wang Y; Dong H; Lu J; Scheininger T; Ewers M; Jessen F; Zuo XN; Han Y
    Alzheimers Res Ther; 2019 Jun; 11(1):50. PubMed ID: 31159873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.
    Soldan A; Pettigrew C; Lu Y; Wang MC; Selnes O; Albert M; Brown T; Ratnanather JT; Younes L; Miller MI;
    Hum Brain Mapp; 2015 Jul; 36(7):2826-41. PubMed ID: 25879865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of APOE ε4 genotype and lifestyle with cognitive function among Chinese adults aged 80 years and older: A cross-sectional study.
    Jin X; He W; Zhang Y; Gong E; Niu Z; Ji J; Li Y; Zeng Y; Yan LL
    PLoS Med; 2021 Jun; 18(6):e1003597. PubMed ID: 34061824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential impact of ApoE ε4 on cortical activation during famous face recognition in cognitively intact individuals and patients with amnestic mild cognitive impairment.
    Frank G; Hennig-Fast K; Klünemann HH; Schmitz G; Greenlee MW
    Alzheimer Dis Assoc Disord; 2011; 25(3):250-61. PubMed ID: 21192235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.